Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology
|
Buy Now
Dietary Flavonoids Interfere with Cancer Radiotherapy (Paperback)
Loot Price: R1,765
Discovery Miles 17 650
|
|
Dietary Flavonoids Interfere with Cancer Radiotherapy (Paperback)
Expected to ship within 12 - 17 working days
|
In parallel with the continuous rise of cancer incidence, efficient
treatment becomes an increasingly important public health concern.
Radiotherapy has remained one of the most important anticancer
approaches for clinical management of a variety of human tumours,
as at least half of all oncological patients receive this therapy
at some stages of their disease. With the hope to attain greater
anticancer response, the interest in using natural plant-derived
products as complementary treatments to conventional radiotherapy
has substantially increased in the recent years. However, the
interactions between phytochemicals and ionizing radiation are not
always known and can be often unpredictable. Therefore, in this
book, the current findings about the combined treatments of
malignant cells with radiation and flavonoids, the largest group of
human dietary plant polyphenols, are described. These data show
that under carefully chosen dosage-schedule regimens, certain
flavonoids or their natural mixtures can behave as potent
radiosensitizers, augmenting radiotherapeutic efficacy in different
preclinical cancer models. Such radio-sensitising action of
flavonoids can be achieved through modulation of the redox status
and suppression of several cellular survival pathways activated by
radiotherapy, ultimately leading to the death of malignant cells.
As flavonoids can concurrently protect normal healthy cells from
irradiation-induced injury and thereby minimize toxic adverse
reactions, use of these plant-derived agents as complementary
approach to radiotherapy might open new avenues for enhancement of
clinical outcome. Therefore, combining conventional anticancer
modalities with conscious intake of flavonoid supplements as
adjuvant agents might be an important future strategy to boost the
therapeutic success in the treatment of various human malignancies.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.